Skip to content

Efeect of Satvavajaya chikitsa,Jaladhara and Shreekhandasava in Madatyaya

â??An open label clinical study to evaluate the effect of Satvavajaya chikitsa, Jaladhara and Shreekhandasava in the management of madatyaya wsr alcohol withdrawal syndromee - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091269
Enrollment
20
Registered
2025-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F101- Alcohol abuse

Interventions

Intervention1: Satvavajaya -30min sessions will beh eld daily in between 4pm to 5pm. Jaladhaara -Dhara with 1½ liter of jala every day int the morning in between 8:00 to 11 am for 30 minu

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosed cases of Madatyaya wsr Alcohol Withdrawal Syndrome as per the diagnostic criteria 2. Ages eligible for study 18 to 70 years of age irrespective of socioeconomic status 3. Both male and female are eligible for the study 4. Participants or relatives willing to give informed consent and comply with study procedures

Exclusion criteria

Exclusion criteria: 1.Ascites clinical gate more than 3 2.Pregnant women and lactating mothers 3. Systemic diseases which interfere with disease process and present clinical trial 4.Patient suffering from the other type of addiction

Design outcomes

Primary

MeasureTime frame
Parameters will be scored by standard method and will be assessed before and after treatment on Seth 14th day 1diagnosed cases of Madatyaya wsr alcohol withdrawal syndrome as per the diagnostic criteria CIWA-Ar scale 2 Manasika bhava scale statistical analysis All scored parameters will be analyzed statistically after the treatment on 14th days all the subjective parameters and scales will be assessed using Wilcoxon signed rank testTimepoint: Parameters will be scored by standard method and will be assessed before and after treatment on 0th 14th day ( at 2 weeks)

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Shrilatha kamath T
shri9503@gmail.com9964899638

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026